Plasma copeptin and markers of arterial disorder in patients with type 2 diabetes, a cross-sectional study
Authors' conclusion
Plasma copeptin may be a helpful surrogate for identifying individuals at higher risk for arterial disorders.
Study context
- Population
- Patients with T2D aged 55–65 years with no history of cardiovascular disease (CVD) at baseline, CARDIPP study
- Participants
- 519 patients
- Outcome
- Association of copeptin, MRproADM and MRproANP with toe brachial index (TBI) and aortic pulse wave velocity (aPWV)
Main finding
As reported in the abstract
Copeptin and toe brachial index (TBI): β (CI −0.0035- (−0.0005), p = 0.010)
−0.0020
Copeptin and aortic pulse wave velocity (aPWV): β
0.023
CI 0.002–0.044p = 0.035
Observational data: associations, not effects.
Original publication
Plasma copeptin and markers of arterial disorder in patients with type 2 diabetes, a cross-sectional study. Cardiovasc Diabetol. Published 12 June 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →